HILL: The efficacy and safety of hepatic arterial infusion chemotherapy with FOLFOX regimen combine lenvatinib and durvalumab in unresectable hepatocellular carcinoma: A prospective, phase II, single-armed, clinical trial

被引：0
|
作者：
Li, S. [1 ]
Lu, L. [1 ]
Wang, Q. [2 ]
Zhao, R. [3 ]
Mei, J. [1 ]
Li, J-B. [4 ]
Zheng, L. [5 ]
Wei, W. [3 ]
Guo, R. [3 ]
机构：
[1] Sun Yat Sen Univ Canc Ctr, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Liver Surg, Guangzhou, Peoples R China
[2] Sun Yat Sen Univ Canc Ctr, Radiat Oncol, Guangzhou, Peoples R China
[3] Sun Yat Sen Univ Canc Ctr, Liver Surg, Guangzhou, Peoples R China
[4] Sun Yat Sen Univ Canc Ctr, Clin Res, Guangzhou, Peoples R China
[5] Sun Yat Sen Univ Canc Ctr, Dept Imaging, Guangzhou, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.08.1042
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
982P
引用
收藏
页码：S670 / S671
页数：2
相关论文
共 50 条
  • [21] Hepatic arterial infusion chemotherapy (HAIC) with oxaliplatin, fluorouracil, and leucovorin (FOLFOX) versus transarterial chemoembolization (TACE) for unresectable hepatocellular carcinoma (HCC): A randomised phase III trial
    Shi, M.
    Li, Q.
    He, M.
    Guo, R.
    ANNALS OF ONCOLOGY, 2020, 31 : S688 - S688
  • [22] Envafolimab plus lenvatinib and transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: a prospective, single-arm, phase II study
    Chen, Yiwen
    Zhang, Junlei
    Hu, Wendi
    Li, Xiang
    Sun, Ke
    Shen, Yan
    Zhang, Min
    Wu, Jian
    Gao, Shunliang
    Yu, Jun
    Que, Risheng
    Zhang, Yun
    Yang, Fuchun
    Xia, Weiliang
    Zhang, Aibin
    Tang, Xiaofeng
    Bai, Xueli
    Liang, Tingbo
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2024, 9 (01)
  • [23] Efficacy and safety of hepatic arterial infusion chemotherapy combined with lenvatinib and PD-1 inhibitors for advanced hepatocellular carcinoma with macrovascular invasion
    Zhang, Yufeng
    Zhang, Haiyan
    Xu, Haoqian
    Wang, Ying
    Feng, Long
    Yi, Fengming
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2024, 22 (01)
  • [24] Donafenib combined with hepatic artery infusion chemotherapy (HAIC) and sintilimab for unresectable hepatocellular carcinoma (uHCC): A prospective, single-arm phase II trial (DoHAICs study)
    Zhang, W.
    Gao, W.
    Liu, C.
    Li, G.
    Zhang, Q.
    Zhou, H.
    Fang, F.
    Li, H.
    Cui, Y.
    Wu, Q.
    Zhu, X.
    Li, Q.
    Zhang, N.
    Song, T.
    Lu, W.
    ANNALS OF ONCOLOGY, 2023, 34 : S613 - S613
  • [25] Donafenib combined with hepatic artery infusion chemotherapy (HAIC) and sintilimab for unresectable hepatocellular carcinoma (uHCC): A prospective, single-arm phase II trial (DoHAICs study).
    Zhang, Wei
    Gao, Wei
    Liu, Chen
    Li, Guangtao
    Zhang, Qin
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [26] FOXAI: a phase II trial evaluating the efficacy and safety of hepatic arterial infusion of oxaliplatin plus fluorouracil/leucovorin for advanced hepatocellular carcinoma
    Lyu, Ning
    Lin, Youen
    Kong, Yanan
    Zhang, Zhenfeng
    Liu, Longzhong
    Zheng, Lie
    Mu, Luwen
    Wang, Jianpeng
    Li, Xishan
    Pan, Tao
    Xie, Qiankun
    Liu, Yaru
    Lin, Aihua
    Wu, Peihong
    Zhao, Ming
    GUT, 2018, 67 (02) : 395 - U258
  • [27] Hepatic arterial infusion of oxaliplatin plus raltitrexed in patients with unresectable hepatocellular carcinoma (HAIROX): A phase II, single-arm, prospective study.
    Chen, Shiguang
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [28] Efficacy and safety of hepatic arterial infusion chemotherapy combined with programmed cell death protein-1 antibody and lenvatinib for advanced hepatocellular carcinoma
    Xu, Yongkang
    Fu, Shumin
    Mao, Ye
    Huang, Shenglan
    Li, Dan
    Wu, Jianbing
    FRONTIERS IN MEDICINE, 2022, 9
  • [29] Hepatic artery infusion chemotherapy (HAIC) combined with camrelizumab and apatinib as conversion therapy for initial unresectable hepatocellular carcinoma (HCC): A prospective, single-arm phase II trial
    Zhou, X.
    Zhu, H.
    Gao, H.
    Niu, Z.
    Liu, M.
    Wang, H.
    Kong, X.
    Ma, C.
    Yang, F.
    Hao, Y.
    Zhang, S.
    Lu, J.
    ANNALS OF ONCOLOGY, 2024, 35 : S1489 - S1489
  • [30] A PHASE II TRIAL OF HEPATIC ARTERIAL INFUSION CHEMOTHERAPY WITH CISPLATIN FOR ADVANCED HEPATOCELLULAR CARCINOMA WITH PORTAL VEIN TUMOR THROMBOSIS
    Furuse, J.
    Ikeda, M.
    Okusaka, T.
    Nakachi, K.
    Morizane, C.
    Ueno, H.
    Yamaura, H.
    Inaba, Y.
    Satake, M.
    Arai, Y.
    ANNALS OF ONCOLOGY, 2008, 19 : 178 - 178
12345